Unavailable
Unavailable
Date | Price Target | Rating | Analyst |
---|---|---|---|
5/16/2022 | $6.00 → $5.00 | Outperform → Neutral | Robert W. Baird |
4/20/2022 | $4.00 → $5.00 | Neutral → Underweight | Piper Sandler |
1/10/2022 | $8.00 → $5.00 | Neutral | Citigroup |
12/28/2021 | $15.00 → $4.00 | Buy → Neutral | Goldman Sachs |
12/27/2021 | $22.00 → $6.50 | Overweight → Equal-Weight | Barclays |
12/23/2021 | $14.00 → $4.00 | Overweight → Neutral | Piper Sandler |
12/17/2021 | $10.00 | Neutral | JP Morgan |
9/29/2021 | $30.00 → $8.00 | Buy → Neutral | Citigroup |
DENVER, May 20, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), welcomes John Koehn as its Senior Vice President of External Affairs as of May 13, 2024. John brings a wealth of experience in healthcare management and a proven track record of success in areas critical to InnovAge's mission and growth, including P&L and risk management, long-term care, provider relations, and business development. John has had exceptional success in fostering close relationships with key stakeholders to drive program manageme
DENVER, Aug. 14, 2023 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced the appointment of Teresa Sparks to its Board of Directors, effective immediately. Sparks joins InnovAge's Board as Sean Traynor of Welsh, Carson, Anderson & Stowe steps down. The InnovAge team and Board thank Mr. Traynor for his service. "Teresa's diverse experience across multiple sectors, including in financial services, life sciences, specialty pharmacy, healthcare services, and technology, is a huge asset and co
DENVER, March 30, 2023 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced the appointment of Patty Fontneau to its Board of Directors, effective immediately. Fontneau joins InnovAge's Board as Pavithra Mahesh of Apax Partners and Caroline Dechert of Welsh, Carson, Anderson & Stowe simultaneously step down from their positions with the Board. These changes maintain the participation of the investment firms while adding additional independent and community representation on the Board. The Inno
4 - InnovAge Holding Corp. (0001834376) (Issuer)
4 - InnovAge Holding Corp. (0001834376) (Issuer)
4 - InnovAge Holding Corp. (0001834376) (Issuer)
DENVER, Aug. 27, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced it will release its 2024 fiscal fourth quarter and full year financial results on Tuesday, September 10, 2024, after market close. In conjunction, the Company will host a conference call to review the results at 5 p.m. E.T. Conference Call DetailsA live audio webcast of the call will be available on the Company's website, https://investor.innovage.com/. A replay of the call will be avai
DENVER, April 23, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced it will release its 2024 fiscal third quarter financial results on Tuesday, May 7, 2024, after market close. In conjunction, the Company will host a conference call to review the results at 5 p.m. E.T. Conference Call DetailsA live audio webcast of the call will be available on the Company's website, https://investor.innovage.com/. A replay of the call will be available via webcast for
DENVER, Jan. 23, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced it will release its 2024 fiscal second quarter financial results on Tuesday, February 6, 2024, after market close. In conjunction, the Company will host a conference call to review the results at 5 p.m. E.T. Conference Call DetailsA live audio webcast of the call will be available on the Company's website, https://investor.innovage.com/. A replay of the call will be available via webc
Robert W. Baird downgraded InnovAge from Outperform to Neutral and set a new price target of $5.00 from $6.00 previously
Piper Sandler downgraded InnovAge from Neutral to Underweight and set a new price target of $5.00 from $4.00 previously
Citigroup resumed coverage of InnovAge with a rating of Neutral and set a new price target of $5.00 from $8.00 previously
InnovAge Holding (NASDAQ:INNV) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. This is a 20 percent increase over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $193.073 million which beat the analyst consensus estimate of $188.246 million by 2.56 percent. This is a 11.90 percent increase over sales of $172.539 million the same period last year.
Gainers GeneDx Hldgs (NASDAQ:WGS) shares increased by 21.8% to $13.4 during Monday's after-market session. The market value of their outstanding shares is at $349.1 million. The company's, Q1 earnings came out today. InnovAge Holding (NASDAQ:INNV) shares increased by 7.25% to $3.99. The market value of their outstanding shares is at $542.2 million. Mustang Bio (NASDAQ:MBIO) shares increased by 5.48% to $0.25. The market value of their outstanding shares is at $2.5 million. Lucid Diagnostics (NASDAQ:LUCD) stock moved upwards by 5.23% to $0.79. The market value of their outstanding shares is at $38.1 million. Seelos Therapeutics (NASDAQ:SEEL) shares increased by 4.88% to $0.29. The market
DENVER, Sept. 16, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge") (NASDAQ:INNV), a leading Program of All-inclusive Care for the Elderly (PACE) provider, has been selected as a research partner for a national study exploring how to prevent falls by seniors. This September's National PACE Awareness Month and Falls Prevention Month observances emphasize the impact of this timely and critical work aimed at reducing dangerous falls by seniors, as well as helping many others facing a wide range of health conditions. According to the CDC, falls are the leading cause of injury and death among older adults, with one in four adults aged 65 and older experiencing a fall each year. Inno
DENVER, Aug. 27, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced it will release its 2024 fiscal fourth quarter and full year financial results on Tuesday, September 10, 2024, after market close. In conjunction, the Company will host a conference call to review the results at 5 p.m. E.T. Conference Call DetailsA live audio webcast of the call will be available on the Company's website, https://investor.innovage.com/. A replay of the call will be avai
SACRAMENTO, Calif., Aug. 16, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), celebrated the fourth anniversary of its Sacramento, California center with community members, local representatives, businesses, healthcare providers, and other valued partners. "The demand for affordable, reliable healthcare for seniors is growing rapidly," said InnovAge President and CEO Patrick Blair. "Along with our Eskaton and Adventist Health joint-venture partners, we are proud to celebrate the continued growt
10-K - InnovAge Holding Corp. (0001834376) (Filer)
8-K - InnovAge Holding Corp. (0001834376) (Filer)
8-K - InnovAge Holding Corp. (0001834376) (Filer)